newsfilter
← Latest News
Business Wire·

Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update

- Topline Results from PROSERA Phase 3 Expected in February 2026 - - First Site Activated for Registrational Phase 3 SERANATA Study in PH-ILD - - Cash, cash equivalents and marketable securities totaled $180 million